Electric Therapy Traction Table Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 112 |
The global Human Pain Management Drug market was valued at US$ 74080 million in 2022 and is projected to reach US$ 97620 million by 2029, at a CAGR of 4.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
OTC Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Human Pain Management Drug include AbbVie Inc. (Allergan plc), Bristol Myers Squibb Co., Sanofi S.A., Boehringer Ingelheim International GmbH, Pfizer Inc., Zydus Lifesciences Ltd. (Cadila Pharmaceuticals), GSK plc., Abbott Laboratories, Inc. and Novartis AG, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
Pain relievers, including acetaminophen, NSAIDs and opioids, can ease temporary aches and chronic pain.
This report aims to provide a comprehensive presentation of the global market for Human Pain Management Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Pain Management Drug. This report contains market size and forecasts of Human Pain Management Drug in global, including the following market information:
Global Human Pain Management Drug Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Human Pain Management Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Human Pain Management Drug Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Human Pain Management Drug Market Segment Percentages, by Type, 2022 (%)
OTC
Rx
Global Human Pain Management Drug Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Human Pain Management Drug Market Segment Percentages, by Application, 2022 (%)
Hospital
Retail Pharmacy
Other
Global Human Pain Management Drug Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Human Pain Management Drug Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Human Pain Management Drug revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Human Pain Management Drug revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
AbbVie Inc. (Allergan plc)
Bristol Myers Squibb Co.
Sanofi S.A.
Boehringer Ingelheim International GmbH
Pfizer Inc.
Zydus Lifesciences Ltd. (Cadila Pharmaceuticals)
GSK plc.
Abbott Laboratories, Inc.
Novartis AG
Johnson & Johnson (Janssen Pharmaceuticals, Inc.)
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceuticals Ltd.
Mallinckrodt Pharmaceuticals
Endo Pharmaceuticals Inc.
Bayer AG
F. Hoffmann-La Roche Ltd.
Procter & Gamble
AstraZeneca
Cardinal Health
Perrigo Company Plc.
Bausch Health Companies Inc.
Viatris
Amneal Pharmaceuticals
Purdue Pharmaceuticals L.P.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Human Pain Management Drug, market overview.
Chapter 2: Global Human Pain Management Drug market size in revenue.
Chapter 3: Detailed analysis of Human Pain Management Drug company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Human Pain Management Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Human Pain Management Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Human Pain Management Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Human Pain Management Drug Overall Market Size
2.1 Global Human Pain Management Drug Market Size: 2022 VS 2029
2.2 Global Human Pain Management Drug Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Human Pain Management Drug Players in Global Market
3.2 Top Global Human Pain Management Drug Companies Ranked by Revenue
3.3 Global Human Pain Management Drug Revenue by Companies
3.4 Top 3 and Top 5 Human Pain Management Drug Companies in Global Market, by Revenue in 2022
3.5 Global Companies Human Pain Management Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Human Pain Management Drug Players in Global Market
3.6.1 List of Global Tier 1 Human Pain Management Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 Human Pain Management Drug Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Human Pain Management Drug Market Size Markets, 2022 & 2029
4.1.2 OTC
4.1.3 Rx
4.2 By Type - Global Human Pain Management Drug Revenue & Forecasts
4.2.1 By Type - Global Human Pain Management Drug Revenue, 2018-2023
4.2.2 By Type - Global Human Pain Management Drug Revenue, 2024-2029
4.2.3 By Type - Global Human Pain Management Drug Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Human Pain Management Drug Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Retail Pharmacy
5.1.4 Other
5.2 By Application - Global Human Pain Management Drug Revenue & Forecasts
5.2.1 By Application - Global Human Pain Management Drug Revenue, 2018-2023
5.2.2 By Application - Global Human Pain Management Drug Revenue, 2024-2029
5.2.3 By Application - Global Human Pain Management Drug Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Human Pain Management Drug Market Size, 2022 & 2029
6.2 By Region - Global Human Pain Management Drug Revenue & Forecasts
6.2.1 By Region - Global Human Pain Management Drug Revenue, 2018-2023
6.2.2 By Region - Global Human Pain Management Drug Revenue, 2024-2029
6.2.3 By Region - Global Human Pain Management Drug Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Human Pain Management Drug Revenue, 2018-2029
6.3.2 US Human Pain Management Drug Market Size, 2018-2029
6.3.3 Canada Human Pain Management Drug Market Size, 2018-2029
6.3.4 Mexico Human Pain Management Drug Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Human Pain Management Drug Revenue, 2018-2029
6.4.2 Germany Human Pain Management Drug Market Size, 2018-2029
6.4.3 France Human Pain Management Drug Market Size, 2018-2029
6.4.4 U.K. Human Pain Management Drug Market Size, 2018-2029
6.4.5 Italy Human Pain Management Drug Market Size, 2018-2029
6.4.6 Russia Human Pain Management Drug Market Size, 2018-2029
6.4.7 Nordic Countries Human Pain Management Drug Market Size, 2018-2029
6.4.8 Benelux Human Pain Management Drug Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Human Pain Management Drug Revenue, 2018-2029
6.5.2 China Human Pain Management Drug Market Size, 2018-2029
6.5.3 Japan Human Pain Management Drug Market Size, 2018-2029
6.5.4 South Korea Human Pain Management Drug Market Size, 2018-2029
6.5.5 Southeast Asia Human Pain Management Drug Market Size, 2018-2029
6.5.6 India Human Pain Management Drug Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Human Pain Management Drug Revenue, 2018-2029
6.6.2 Brazil Human Pain Management Drug Market Size, 2018-2029
6.6.3 Argentina Human Pain Management Drug Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Human Pain Management Drug Revenue, 2018-2029
6.7.2 Turkey Human Pain Management Drug Market Size, 2018-2029
6.7.3 Israel Human Pain Management Drug Market Size, 2018-2029
6.7.4 Saudi Arabia Human Pain Management Drug Market Size, 2018-2029
6.7.5 UAE Human Pain Management Drug Market Size, 2018-2029
7 Human Pain Management Drug Companies Profiles
7.1 AbbVie Inc. (Allergan plc)
7.1.1 AbbVie Inc. (Allergan plc) Company Summary
7.1.2 AbbVie Inc. (Allergan plc) Business Overview
7.1.3 AbbVie Inc. (Allergan plc) Human Pain Management Drug Major Product Offerings
7.1.4 AbbVie Inc. (Allergan plc) Human Pain Management Drug Revenue in Global Market (2018-2023)
7.1.5 AbbVie Inc. (Allergan plc) Key News & Latest Developments
7.2 Bristol Myers Squibb Co.
7.2.1 Bristol Myers Squibb Co. Company Summary
7.2.2 Bristol Myers Squibb Co. Business Overview
7.2.3 Bristol Myers Squibb Co. Human Pain Management Drug Major Product Offerings
7.2.4 Bristol Myers Squibb Co. Human Pain Management Drug Revenue in Global Market (2018-2023)
7.2.5 Bristol Myers Squibb Co. Key News & Latest Developments
7.3 Sanofi S.A.
7.3.1 Sanofi S.A. Company Summary
7.3.2 Sanofi S.A. Business Overview
7.3.3 Sanofi S.A. Human Pain Management Drug Major Product Offerings
7.3.4 Sanofi S.A. Human Pain Management Drug Revenue in Global Market (2018-2023)
7.3.5 Sanofi S.A. Key News & Latest Developments
7.4 Boehringer Ingelheim International GmbH
7.4.1 Boehringer Ingelheim International GmbH Company Summary
7.4.2 Boehringer Ingelheim International GmbH Business Overview
7.4.3 Boehringer Ingelheim International GmbH Human Pain Management Drug Major Product Offerings
7.4.4 Boehringer Ingelheim International GmbH Human Pain Management Drug Revenue in Global Market (2018-2023)
7.4.5 Boehringer Ingelheim International GmbH Key News & Latest Developments
7.5 Pfizer Inc.
7.5.1 Pfizer Inc. Company Summary
7.5.2 Pfizer Inc. Business Overview
7.5.3 Pfizer Inc. Human Pain Management Drug Major Product Offerings
7.5.4 Pfizer Inc. Human Pain Management Drug Revenue in Global Market (2018-2023)
7.5.5 Pfizer Inc. Key News & Latest Developments
7.6 Zydus Lifesciences Ltd. (Cadila Pharmaceuticals)
7.6.1 Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Company Summary
7.6.2 Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Business Overview
7.6.3 Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Human Pain Management Drug Major Product Offerings
7.6.4 Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Human Pain Management Drug Revenue in Global Market (2018-2023)
7.6.5 Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Key News & Latest Developments
7.7 GSK plc.
7.7.1 GSK plc. Company Summary
7.7.2 GSK plc. Business Overview
7.7.3 GSK plc. Human Pain Management Drug Major Product Offerings
7.7.4 GSK plc. Human Pain Management Drug Revenue in Global Market (2018-2023)
7.7.5 GSK plc. Key News & Latest Developments
7.8 Abbott Laboratories, Inc.
7.8.1 Abbott Laboratories, Inc. Company Summary
7.8.2 Abbott Laboratories, Inc. Business Overview
7.8.3 Abbott Laboratories, Inc. Human Pain Management Drug Major Product Offerings
7.8.4 Abbott Laboratories, Inc. Human Pain Management Drug Revenue in Global Market (2018-2023)
7.8.5 Abbott Laboratories, Inc. Key News & Latest Developments
7.9 Novartis AG
7.9.1 Novartis AG Company Summary
7.9.2 Novartis AG Business Overview
7.9.3 Novartis AG Human Pain Management Drug Major Product Offerings
7.9.4 Novartis AG Human Pain Management Drug Revenue in Global Market (2018-2023)
7.9.5 Novartis AG Key News & Latest Developments
7.10 Johnson & Johnson (Janssen Pharmaceuticals, Inc.)
7.10.1 Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Company Summary
7.10.2 Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Business Overview
7.10.3 Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Human Pain Management Drug Major Product Offerings
7.10.4 Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Human Pain Management Drug Revenue in Global Market (2018-2023)
7.10.5 Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Key News & Latest Developments
7.11 Sun Pharmaceutical Industries Ltd.
7.11.1 Sun Pharmaceutical Industries Ltd. Company Summary
7.11.2 Sun Pharmaceutical Industries Ltd. Business Overview
7.11.3 Sun Pharmaceutical Industries Ltd. Human Pain Management Drug Major Product Offerings
7.11.4 Sun Pharmaceutical Industries Ltd. Human Pain Management Drug Revenue in Global Market (2018-2023)
7.11.5 Sun Pharmaceutical Industries Ltd. Key News & Latest Developments
7.12 Teva Pharmaceuticals Ltd.
7.12.1 Teva Pharmaceuticals Ltd. Company Summary
7.12.2 Teva Pharmaceuticals Ltd. Business Overview
7.12.3 Teva Pharmaceuticals Ltd. Human Pain Management Drug Major Product Offerings
7.12.4 Teva Pharmaceuticals Ltd. Human Pain Management Drug Revenue in Global Market (2018-2023)
7.12.5 Teva Pharmaceuticals Ltd. Key News & Latest Developments
7.13 Mallinckrodt Pharmaceuticals
7.13.1 Mallinckrodt Pharmaceuticals Company Summary
7.13.2 Mallinckrodt Pharmaceuticals Business Overview
7.13.3 Mallinckrodt Pharmaceuticals Human Pain Management Drug Major Product Offerings
7.13.4 Mallinckrodt Pharmaceuticals Human Pain Management Drug Revenue in Global Market (2018-2023)
7.13.5 Mallinckrodt Pharmaceuticals Key News & Latest Developments
7.14 Endo Pharmaceuticals Inc.
7.14.1 Endo Pharmaceuticals Inc. Company Summary
7.14.2 Endo Pharmaceuticals Inc. Business Overview
7.14.3 Endo Pharmaceuticals Inc. Human Pain Management Drug Major Product Offerings
7.14.4 Endo Pharmaceuticals Inc. Human Pain Management Drug Revenue in Global Market (2018-2023)
7.14.5 Endo Pharmaceuticals Inc. Key News & Latest Developments
7.15 Bayer AG
7.15.1 Bayer AG Company Summary
7.15.2 Bayer AG Business Overview
7.15.3 Bayer AG Human Pain Management Drug Major Product Offerings
7.15.4 Bayer AG Human Pain Management Drug Revenue in Global Market (2018-2023)
7.15.5 Bayer AG Key News & Latest Developments
7.16 F. Hoffmann-La Roche Ltd.
7.16.1 F. Hoffmann-La Roche Ltd. Company Summary
7.16.2 F. Hoffmann-La Roche Ltd. Business Overview
7.16.3 F. Hoffmann-La Roche Ltd. Human Pain Management Drug Major Product Offerings
7.16.4 F. Hoffmann-La Roche Ltd. Human Pain Management Drug Revenue in Global Market (2018-2023)
7.16.5 F. Hoffmann-La Roche Ltd. Key News & Latest Developments
7.17 Procter & Gamble
7.17.1 Procter & Gamble Company Summary
7.17.2 Procter & Gamble Business Overview
7.17.3 Procter & Gamble Human Pain Management Drug Major Product Offerings
7.17.4 Procter & Gamble Human Pain Management Drug Revenue in Global Market (2018-2023)
7.17.5 Procter & Gamble Key News & Latest Developments
7.18 AstraZeneca
7.18.1 AstraZeneca Company Summary
7.18.2 AstraZeneca Business Overview
7.18.3 AstraZeneca Human Pain Management Drug Major Product Offerings
7.18.4 AstraZeneca Human Pain Management Drug Revenue in Global Market (2018-2023)
7.18.5 AstraZeneca Key News & Latest Developments
7.19 Cardinal Health
7.19.1 Cardinal Health Company Summary
7.19.2 Cardinal Health Business Overview
7.19.3 Cardinal Health Human Pain Management Drug Major Product Offerings
7.19.4 Cardinal Health Human Pain Management Drug Revenue in Global Market (2018-2023)
7.19.5 Cardinal Health Key News & Latest Developments
7.20 Perrigo Company Plc.
7.20.1 Perrigo Company Plc. Company Summary
7.20.2 Perrigo Company Plc. Business Overview
7.20.3 Perrigo Company Plc. Human Pain Management Drug Major Product Offerings
7.20.4 Perrigo Company Plc. Human Pain Management Drug Revenue in Global Market (2018-2023)
7.20.5 Perrigo Company Plc. Key News & Latest Developments
7.21 Bausch Health Companies Inc.
7.21.1 Bausch Health Companies Inc. Company Summary
7.21.2 Bausch Health Companies Inc. Business Overview
7.21.3 Bausch Health Companies Inc. Human Pain Management Drug Major Product Offerings
7.21.4 Bausch Health Companies Inc. Human Pain Management Drug Revenue in Global Market (2018-2023)
7.21.5 Bausch Health Companies Inc. Key News & Latest Developments
7.22 Viatris
7.22.1 Viatris Company Summary
7.22.2 Viatris Business Overview
7.22.3 Viatris Human Pain Management Drug Major Product Offerings
7.22.4 Viatris Human Pain Management Drug Revenue in Global Market (2018-2023)
7.22.5 Viatris Key News & Latest Developments
7.23 Amneal Pharmaceuticals
7.23.1 Amneal Pharmaceuticals Company Summary
7.23.2 Amneal Pharmaceuticals Business Overview
7.23.3 Amneal Pharmaceuticals Human Pain Management Drug Major Product Offerings
7.23.4 Amneal Pharmaceuticals Human Pain Management Drug Revenue in Global Market (2018-2023)
7.23.5 Amneal Pharmaceuticals Key News & Latest Developments
7.24 Purdue Pharmaceuticals L.P.
7.24.1 Purdue Pharmaceuticals L.P. Company Summary
7.24.2 Purdue Pharmaceuticals L.P. Business Overview
7.24.3 Purdue Pharmaceuticals L.P. Human Pain Management Drug Major Product Offerings
7.24.4 Purdue Pharmaceuticals L.P. Human Pain Management Drug Revenue in Global Market (2018-2023)
7.24.5 Purdue Pharmaceuticals L.P. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LED Light-Up Blanket Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 116 |
Pelvic Floor Functional Magnetic Stimulator Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 115 |
Multi-Modality Biofeedback System Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 112 |
High Frequency Evaluation and Therapy Device Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 115 |
Choose License Type
Why Choose Us ?
24/7 Research support
Quality assurance
Information security
The report efficiently evaluates the market from various dimensions to deliver an
end-product that is informative, elaborate, and accurate and includes detailed
market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast.
The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of
xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the
industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by Types, Applications, Technology, End-use Industries, and Regions.
The report presents the current market size, and market forecast, market
opportunities, key drivers and restraints, regulatory scenario, industry trend, PESTLE
analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing
initiatives, pricing analysis, competitive landscape which help businesses in
decision making. The analysis data is based on current and historical market trends
which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any
organization to gain insight into specific business sector, aligned with specific area
of interest. Thus, SMI offers more accurate, pragmatic, and actionable information
specifically tailored to suit your business needs.
